Hearing Loss Trial, Recruiting (NCT06377215)

Hearing Loss Trial, Recruiting NCT06377215 Sponsor: University of South Florida Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06377215 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18–35 years old with normal hearing, OR between 60–80 years old with normal hearing, OR between 60–80 years old with a moderate hearing loss in both ears.
If you have normal hearing, your hearing test results must fall within a specific healthy range at various sound frequencies (confirm with trial site for exact numbers).
If you have hearing loss, it must affect both ears similarly and be caused by inner ear or nerve-related issues (not a blockage or structural problem), within a specific moderate range of severity.
If you have hearing loss, you are either already using hearing aids or your hearing loss level means you could benefit from them.
You speak English fluently, as the speech tests in this study are conducted in English.
You score above 22 on a standard memory and thinking assessment called the MoCA, showing that your thinking and memory skills are within a range that allows you to complete the study tasks.
The study aims to include roughly equal numbers of male and female participants.

Who may not be able to join:

You have been treated for a head injury in the past 12 months.
You have been treated for a traumatic brain injury in the past 12 months.
You have been treated for epilepsy or seizures in the past 12 months.
You have been treated for any other neurological (brain or nervous system) condition in the past 12 months.
You have had ear surgery in the past 12 months.
Your hearing loss has been actively changing or fluctuating recently.
You have been treated for Acute Meniere's disease (an inner ear condition causing dizziness and hearing changes) in the past 12 months.
You have been treated for labyrinthitis (an inner ear infection causing dizziness) in the past 12 months.
You have a hearing loss caused by a blockage or structural problem in the ear (rather than inner ear or nerve-related causes).
You are currently taking medications known to be harmful to hearing (confirm with trial site for specific medications).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06377215

Sponsor: University of South Florida

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

More information: https://clinicaltrials.gov/study/NCT06377215

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18–35 years old with normal hearing, OR between 60–80 years old with normal hearing, OR between 60–80 years old with a moderate hearing loss in both ears.
If you have normal hearing, your hearing test results must fall within a specific healthy range at various sound frequencies (confirm with trial site for exact numbers).
If you have hearing loss, it must affect both ears similarly and be caused by inner ear or nerve-related issues (not a blockage or structural problem), within a specific moderate range of severity.
If you have hearing loss, you are either already using hearing aids or your hearing loss level means you could benefit from them.
You speak English fluently, as the speech tests in this study are conducted in English.
You score above 22 on a standard memory and thinking assessment called the MoCA, showing that your thinking and memory skills are within a range that allows you to complete the study tasks.
The study aims to include roughly equal numbers of male and female participants.

Who may not be able to join:

You have been treated for a head injury in the past 12 months.
You have been treated for a traumatic brain injury in the past 12 months.
You have been treated for epilepsy or seizures in the past 12 months.
You have been treated for any other neurological (brain or nervous system) condition in the past 12 months.
You have had ear surgery in the past 12 months.
Your hearing loss has been actively changing or fluctuating recently.
You have been treated for Acute Meniere's disease (an inner ear condition causing dizziness and hearing changes) in the past 12 months.
You have been treated for labyrinthitis (an inner ear infection causing dizziness) in the past 12 months.
You have a hearing loss caused by a blockage or structural problem in the ear (rather than inner ear or nerve-related causes).
You are currently taking medications known to be harmful to hearing (confirm with trial site for specific medications).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of South Florida

Registry

ClinicalTrials.gov

Start date

16 November 2025

Est. completion

1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Digit Identification; Neural Segregation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov